Business Type:
Manufacturer/Factory,Trading Company
Business Range:
Ult Freezer, Biomedical Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Spark ..
Establishment:
2005
R&D Capacity:
OwnBrand, ODM, OEM
Terms of Payment:
LC, T/T
Main Markets:
Australia, Others
OEM/ODM Service
Sample Available

Biomedical Freezer, Deep Freezer, Freezer manufacturer / supplier in China, offering -40celsius~-60celsius Biomedical Freezer (DW-40L348), -25celsius~-30celsius Biomedical Freezer (DW-30L420F), -40celsius~-60celsius Biomedical Freezer (DW-60W258) and so on.

1
    YRS
General Supplier

Contact Supplier

Ms. Judy Li
Sales Manager

Company Profile

Qingdao Haier Biomedical Co., Ltd.
Business Type: Manufacturer/Factory,Trading Company
Main Products: Ult Freezer, Biomedical Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Spark,
Established Year: 2005
OEM/ODM Availability: Yes

Haier Biomedical

Haier Biomedical, or Qingdao Haier Biomedical Co., Ltd., is an association of Haier Group Corporation engaging in biological technology. Haier Biomedical's vision is to become the icon of IoT biological science and technology solutions, adhering to the values as an ecosystem to trust and a platform to share and the mission to enlighten life with intelligence and to be the pioneer to create value in the biological science and technology IoT-based ecosystem. Emphasizing on user experiences, we provide biological science and technology solutions. We started our business in the field of cold storage and have been evolving towards an IoT-based solution provider. <o: P>

Haier Biomedical maintains leading position in the biomedical cold storage industry of China. We have creatively applied the intelligent IoT technology into our cold storage products and developed solutions that could be applied in various life science scenarios. We have also strategically deployed in the molecular diagnosis POCT market.

Haier Biomedical have been engaging in the production and sales of biomedical cold storage products since 2005. Through our development for over a decade, it has a diversified product portfolio consisting of constant temperature, low-temperature and ultra-low temperature products and biosafety products which can satisfy a wide range of needs of end users in terms of blood, vaccine, biosamples, drug and reagent storage and biosafety assurance. Our business presence covers a broad range of sub-categories of the biological science and technology solution market and we have taken a leading position in the global biomedical cold storage industry.

Through technological innovation, Haier Biomedical has ended the long-term monopoly of imported products in the cold storage market in China, and established a broad user base. We have participated in the development of biobank in China through the provision of biobank solution. As of June 30, 2018, our solutions have been applied by 500 biobanks in China, including six national sample banks including the China National Gene Bank, China Marrow Donor Program and China Protein Data Bank, Fuwai Hospital in Beijing, 301 Hospital in Beijing and Western China Hospital in Sichuan. We have gained wide recognition from users of different special fields such as respiration, metabolism, digestion and endocrinology. In addition, our biobank solution is highly praised by overseas user. We have established models for the biobank of a top university and a well-known international biobank in the UK, which has increased our reputation among our users worldwilde.

Through our development for more than a decade, Haier Biomedical continues to innovate in the field of biomedical cold storage. We have 158 patents, including 29 inventions and 102 utility models, and our biomedical cold storage products cover the temperature zones ranging from -196° C to +8° C. <o: P>

Haier Biomedical's solutions can ensure that the biosamples, blood, vaccines, drugs and reagent are always stored at the required temperatures constantly. For instance, by using our vaccine safety solutions, our SSD vaccine refrigerators guarantee the safe temperature of vaccine storage, which can maintain the required constant temperature for a maximum time period of 120 hours in the power-off situation, and maintain normal operation under cloudy and rainy weather for at least seven days, while the requirement of World Health Organization for maintaining the safe temperature is 72 hours. Such solution can guarantee the safe temperature of vaccine storage. In addition, the solution does not rely on the use of battery, which is environmentally friendly and also mitigates the risk of equipment failure due to problem of the battery. <o: P>

Trade Capacity

International Commercial Terms(Incoterms):
FOB, CIF, CFR
Terms of Payment:
LC, T/T
Export Year:
2005-10-28
Main Markets:
Australia, Others
R&D Capacity:
OwnBrand, ODM, OEM

Company Show

Send your message to this supplier

From
To:
Qingdao Haier Biomedical Co., Ltd.
*Message

Enter between 10 to 1,000 characters.

Your Name
Company
Phone